Literature DB >> 15562294

Activation of TRPV1 in the VTA excites dopaminergic neurons and increases chemical- and noxious-induced dopamine release in the nucleus accumbens.

Silvia Marinelli1, Tiziana Pascucci, Giorgio Bernardi, Stefano Puglisi-Allegra, Nicola B Mercuri.   

Abstract

Dopamine (DA)-containing neurons of the ventral tegmental area (VTA) provide dopaminergic input to the nucleus accumbens and to the prefrontal cortex within the mesolimbic pathway. In the present study, we combined electrophysiological recordings and microdialysis techniques to investigate the function of transient receptor potential vanilloid 1 (TRPV1) channel in the VTA. In brain slices, application of the TRPV1 receptor agonist capsaicin increased the firing rate of rat dopamine neurons and in a proportion of tested cells (44%) it also induced a bursting behavior. The effects of capsaicin were concentration dependent. The increase in neuronal firing was dependent on enhanced glutamatergic transmission since it was blocked by the superfusion of the ionotropic glutamate antagonists, CNQX and AP5. Interestingly, microinjection of capsaicin into the VTA and noxious tail stimulation transiently enhanced dopamine release into the nucleus accumbens. Both the in vitro and in vivo effects were mediated by TRPV1 activation in the VTA since they were reduced by co-perfusion of the selective TRPV1 receptor antagonist iodoresineferatoxin. Our data suggest a novel role for TRPV1 channels in the mesencephalon of rat, namely activation of the DA system following a peripheral noxious stimulation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15562294     DOI: 10.1038/sj.npp.1300615

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  42 in total

1.  Short-term increases in transient receptor potential vanilloid-1 mediate stress-induced enhancement of neuronal excitation.

Authors:  Carl Weitlauf; Nicholas J Ward; Wendi S Lambert; Tatiana N Sidorova; Karen W Ho; Rebecca M Sappington; David J Calkins
Journal:  J Neurosci       Date:  2014-11-12       Impact factor: 6.167

2.  TRPV1: a stress response protein in the central nervous system.

Authors:  Karen W Ho; Nicholas J Ward; David J Calkins
Journal:  Am J Neurodegener Dis       Date:  2012-04-01

Review 3.  The behavioral pharmacology of effort-related choice behavior: dopamine, adenosine and beyond.

Authors:  John D Salamone; Merce Correa; Eric J Nunes; Patrick A Randall; Marta Pardo
Journal:  J Exp Anal Behav       Date:  2012-01       Impact factor: 2.468

Review 4.  Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits.

Authors:  J D Salamone; M Correa; A Farrar; S M Mingote
Journal:  Psychopharmacology (Berl)       Date:  2007-01-16       Impact factor: 4.530

5.  Physiology and pharmacology of the vanilloid receptor.

Authors:  Angel Messeguer; Rosa Planells-Cases; Antonio Ferrer-Montiel
Journal:  Curr Neuropharmacol       Date:  2006-01       Impact factor: 7.363

Review 6.  Endocannabinoid-mediated synaptic plasticity and addiction-related behavior.

Authors:  Nimish Sidhpura; Loren H Parsons
Journal:  Neuropharmacology       Date:  2011-06-12       Impact factor: 5.250

7.  Loss of interneuron LTD and attenuated pyramidal cell LTP in Trpv1 and Trpv3 KO mice.

Authors:  Travis E Brown; Anda M Chirila; Benjamin R Schrank; Julie A Kauer
Journal:  Hippocampus       Date:  2013-06-03       Impact factor: 3.899

Review 8.  Moving towards supraspinal TRPV1 receptors for chronic pain relief.

Authors:  Enza Palazzo; Livio Luongo; Vito de Novellis; Liberato Berrino; Francesco Rossi; Sabatino Maione
Journal:  Mol Pain       Date:  2010-10-11       Impact factor: 3.395

9.  TRPV1: a target for next generation analgesics.

Authors:  Louis S Premkumar; Parul Sikand
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

10.  Dopamine, behavioral economics, and effort.

Authors:  John D Salamone; Merce Correa; Andrew M Farrar; Eric J Nunes; Marta Pardo
Journal:  Front Behav Neurosci       Date:  2009-09-07       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.